Articles From: Depomed Reports Second Quarter 2013 Financial Results to Derma Sciences to Participate in the Canaccord Genuity Medical Technology & Diagnostics Forum


2013/8/7
Total revenues increase to $30 million resulting in a profitable and cash flow positive quarter Conference call scheduled for today at 5:00 PM EDT Dial in information included below NEWARK, Calif.
Sign-up for Depomed Reports Second Quarter 2013 Financial Results investment picks
Total revenues increase to $37.5 million and EPS of $0.11 per share Conference call scheduled for today at 5:00 PM EST Dial in information included below NEWARK, Calif.
Sign-up for Depomed Reports Third Quarter 2013 Financial Results investment picks
Cash to support future product acquisitions Depomed to host investor conference call today at 5:00 p.m. EDT, 2:00 p.m. PDT NEWARK, Calif.
Sign-up for Depomed Sells Type 2 Diabetes Royalties And Milestones To PDL BioPharma For $240.5 Million investment picks
2013/12/2
NEWARK, Calif.
Sign-up for Depomed To Present At Piper Jaffray 2013 Healthcare Conference investment picks
2013/9/4
NEWARK, Calif.
Sign-up for Depomed To Present At Stifel Nicolaus Healthcare Conference investment picks
2014/3/5
NEWARK, Calif.
Sign-up for Depomed To Present At The 26th Annual ROTH Conference On Monday, March 10, 2014 investment picks
2014/2/20
NEWARK, Calif.
Sign-up for Depomed To Present At Upcoming Healthcare Conferences investment picks
2014/3/10
NEWARK, Calif.
Sign-up for Depomed To Report Fourth Quarter Fiscal Year 2013 Financial Results On Wednesday, March 12, 2014 investment picks
2013/8/1
NEWARK, Calif.
Sign-up for Depomed To Report Second Quarter Fiscal Year 2013 Financial Results On Wednesday, August 7, 2013 investment picks
NEW YORK , SINGAPORE and SHANGHAI , Dec.
Sign-up for Depth and Breadth of Excellence of Omnicom Agencies On Full Display at Campaign Asia-Pacific Agency of the Year Awards investment picks
TORONTO--A fire caused by the derailment Saturday of a train carrying crude oil and liquefied petroleum gas in Alberta was still burning Monday, and more than 100 people remained evacuated.
Sign-up for Derailed Fuel Cars Still Burning in Alberta investment picks
2014/3/10
SAN DIEGO , March 10, 2014 /PRNewswire/ -- Qualcomm Incorporated (NASDAQ: QCOM) today announced that Derek Aberle , executive vice president of Qualcomm Incorporated and group president has been promoted to president of Qualcomm Incorporated.
Sign-up for Derek Aberle Named Qualcomm President investment picks
Derek Stimson announces filing of Early Warning Report in respect of Rocky Mountain Dealerships Inc. Canada NewsWire Prior to giving effect to the Acquisition, Mr.
Sign-up for Derek Stimson announces filing of Early Warning Report in respect of Rocky Mountain Dealerships Inc. investment picks
2013/11/4
CME Group Inc.'s (CME) third-quarter profit rose 8.6% as the exchange operator's trading volume improved on growth in interest-rate contracts.
Sign-up for Derivatives Shift Lifts CME Earnings investment picks
Derma Sciences, Inc. (Nasdaq:DSCI) , a medical device and pharmaceutical company focused on advanced wound care, today announced a $7.0 million strategic investment in Comvita Limited (NZX:CVT), a global natural health and beauty products company based in New Zealand, with the purchase of approximately 2.3 million newly issued common shares.
Sign-up for Derma Sciences Acquires 7.3% of Comvita to Support Vertical Integration of Key Component in MEDIHONEY® Products investment picks
2014/1/23
Derma Sciences, Inc. (Nasdaq:DSCI), a tissue regeneration company focused on advanced wound care, today announced that it intends to offer shares of its common stock in a public offering.
Sign-up for Derma Sciences Announces Commencement of Public Offering of Common Stock investment picks
2014/1/24
Derma Sciences, Inc. (the “Company”) (Nasdaq: DSCI), a tissue regeneration company focused on advanced wound care, today announced the pricing of an underwritten public offering of 6,521,739 shares of common stock at a price to the public of $11.50 per share.
Sign-up for Derma Sciences Announces Pricing of Underwritten Public Offering of Common Stock investment picks
Derma Sciences, Inc. (Nasdaq:DSCI), a medical device and pharmaceutical company focused on advanced wound care, today announced that total revenue for the full year ended December 31, 2013 is expected to be $79.7 million, up 7.7% compared with 2012.
Sign-up for Derma Sciences Announces Record Revenues for the 2013 Fourth Quarter and Full Year, Introduces 2014 Revenue Guidance, Provides Update on DSC127 Phase 3 Clinical Trials investment picks
2014/1/29
Derma Sciences, Inc. (the “Company”) (Nasdaq: DSCI), a tissue regeneration company focused on advanced wound care, today announced the closing of an underwritten public offering of 7,500,000 shares of common stock at a price to the public of $11.50 per share, which includes the exercise of the underwriters’ option to purchase 978,261 shares of common stock to cover over-allotments.
Sign-up for Derma Sciences Closes $86 Million Underwritten Public Offering of Common Stock, Including Full Over-Allotment investment picks
2014/1/14
Derma Sciences, Inc. (Nasdaq:DSCI), a medical device and pharmaceutical company focused on advanced wound care, announces it has licensed exclusive rights to two novel human placental-derived tissue products for all dermal indications in the advanced wound care and burn markets from BioD LLC, a privately held company based in Memphis, Tenn.
Sign-up for Derma Sciences Enters the Skin Substitute Market with Licensing Agreement for Innovative Amniotic Membrane Wound Care Products investment picks
2014/3/14
Derma Sciences, Inc. (the “Company”) (Nasdaq:DSCI), a tissue regeneration and burn care company focused on advanced wound care, today reported financial and operating results for the three months and year ended December 31, 2013.
Sign-up for Derma Sciences Reports Fourth Quarter Financial Results, Provides Commercial Update Including Sales Force Expansion and Progress in Launching New Placental-Derived Tissue Products investment picks
Derma Sciences, Inc. (Nasdaq: DSCI) , a medical device and pharmaceutical company focused on advanced wound care, today reported financial and operating results for the three and six months ended June 30, 2013.
Sign-up for Derma Sciences Reports Second Quarter Financial Results investment picks
2013/11/13
Derma Sciences, Inc. (Nasdaq:DSCI), a medical device and pharmaceutical company focused on advanced wound care, today reported financial and operating results for the three and nine months ended September 30, 2013.
Sign-up for Derma Sciences Reports Third Quarter Financial Results investment picks
Derma Sciences, Inc. (Nasdaq: DSCI) , a medical device and pharmaceutical company focused on advanced wound care, today reported that it has made an initial shipment of its first honey-based over-the-counter (OTC) product to a leading U.S.-based pharmacy chain.
Sign-up for Derma Sciences Ships First MEDIHONEY over-the-counter Product to Leading U.S. Pharmacy Chain investment picks
2014/3/10
Derma Sciences, Inc. (the “Company”) (Nasdaq:DSCI), a tissue regeneration company focused on advanced wound care, announced today that it will hold a conference call on March 14, 2014 to discuss the financial results for the fourth quarter of 2013.
Sign-up for Derma Sciences to Hold Fourth Quarter Financial Results Conference Call on March 14th investment picks
Derma Sciences, Inc. (Nasdaq: DSCI) , a medical device and pharmaceutical company focused on advanced wound care, announced today that it will hold a conference call on August 12, 2013 to discuss the financial results for the second quarter of 2013.
Sign-up for Derma Sciences to Hold Second Quarter Financial Results Conference Call on August 12th investment picks
2013/11/6
Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and pharmaceutical company focused on advanced wound care, announced today that it will hold a conference call on November 13, 2013 to discuss the financial results for the third quarter of 2013.
Sign-up for Derma Sciences to Hold Third Quarter Financial Results Conference Call on November 13th investment picks
2013/11/25
Derma Sciences, Inc. (Nasdaq:DSCI), a medical device and pharmaceutical company focused on advanced wound care, announced today that Edward J.
Sign-up for Derma Sciences to Participate in the 25th Annual Piper Jaffray Healthcare Conference investment picks
2013/11/12
Derma Sciences, Inc. (Nasdaq:DSCI), a medical device and pharmaceutical company focused on advanced wound care, announced today that Edward J.
Sign-up for Derma Sciences to Participate in the Canaccord Genuity Medical Technology & Diagnostics Forum investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Depomed Reports Second Quarter 2013 Financial Results to Derma Sciences to Participate in the Canaccord Genuity Medical Technology & Diagnostics Forum
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity